Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac diethylamine 2.32% gel in acute ankle sprain
NCT00573768Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of diclofenac diethylammonium in Ankle sprain (3 arms), sponsored by Novartis. Primary endpoint: Pain on Movement on Day 5 (Change From Baseline). Started Nov 2007; status: completed.
02
Drugs
diclofenac diethylammonium
03
Conditions
Ankle sprain
Beyond the preview
Go deeper on NCT00573768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00573768.